These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 4138697)

  • 61. Binding of low-molecular-weight canine factor VIII coagulant from von Willebrand plasma to canine factor VIII-related antigen.
    Benson RE; Johnson GS; Dodds WJ
    Br J Haematol; 1981 Dec; 49(4):541-50. PubMed ID: 6797460
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The specificity of antibodies to factor 8 produced in the rabbit after immunization with human cryoprecipitate.
    Kernoff PB; Rizza CR
    Br J Haematol; 1973 Aug; 25(2):276-7. PubMed ID: 4542215
    [No Abstract]   [Full Text] [Related]  

  • 63. Quantitation of binding of factor VIII antigen to concanavalin A.
    Howard MA; Perkin J; Koutts J; Firkin BG
    Br J Haematol; 1981 Apr; 47(4):607-15. PubMed ID: 6783065
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Re-evaluation of plasmas from patients previously diagnosed as having von Willebrand's disease with the factor VIII-related antigen and ristocetin cofactor assay.
    Ness PM; Hymas PG; Perkins HA
    Am J Clin Pathol; 1979 Jan; 71(1):26-30. PubMed ID: 311154
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Symposium on the blood coagulation and fibrinolysin. (6) Immunological studies on hemophilia A, carriers of hemophilia A and von Willebrand's disease (author's transl)].
    Kamiya T; Ishiguro J; Koie K; Saito H
    Nihon Naika Gakkai Zasshi; 1975 Oct; 64(10):1121-6. PubMed ID: 1081560
    [No Abstract]   [Full Text] [Related]  

  • 66. The immunological properties of factor VIII. I. Studies on the inhibitory activity of specific antisera to human antihemophilic globulin.
    Uszyński L
    Thromb Diath Haemorrh; 1966 Dec; 16(3):558-73. PubMed ID: 5301276
    [No Abstract]   [Full Text] [Related]  

  • 67. [Molecular defect in hemophilia and von Willebrand's disease (author's transl)].
    Fukui H
    Rinsho Byori; 1976 Apr; 24(4):274-8. PubMed ID: 1084430
    [No Abstract]   [Full Text] [Related]  

  • 68. Antigen-biological-activity ratio for factor VIII.
    Hougie C; Sargeant R
    Lancet; 1973 Mar; 1(7803):616-7. PubMed ID: 4120690
    [No Abstract]   [Full Text] [Related]  

  • 69. Measurement of factor VIII related antigen by enzyme linked immunosorbent assay (ELISA).
    Bhargava M; Kumar R
    Indian J Med Res; 1983 Jan; 77():119-21. PubMed ID: 6407987
    [No Abstract]   [Full Text] [Related]  

  • 70. Factor VIII-related antigen (VIII R:AG) in haemophilic patients and in carriers.
    Bowie EJ; Fass DN
    Lancet; 1979 Nov; 2(8151):1049-50. PubMed ID: 91786
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Radioimmunoassay for coagulant factor VIII-related antigen (VIII:CAg).
    Reisner HM; Barrow ES; Graham JB
    Thromb Res; 1979 Jan; 14(1):235-9. PubMed ID: 311531
    [No Abstract]   [Full Text] [Related]  

  • 72. Comparison of Ulex europaeus I lectin binding and factor VIII-related antigen as markers of vascular endothelium in follicular carcinoma of the thyroid.
    Stephenson TJ; Griffiths DW; Mills PM
    Histopathology; 1986 Mar; 10(3):251-60. PubMed ID: 2422104
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A 1973 look at hemophilia and von Willebrand's disease.
    Ratnoff OD
    Proc Inst Med Chic; 1973; 29(9):296-304. PubMed ID: 4581203
    [No Abstract]   [Full Text] [Related]  

  • 74. Antigen/biological-activity ratio for factor VIII.
    Denson WK; Ingram GI
    Lancet; 1973 Jan; 1(7795):157-8. PubMed ID: 4118508
    [No Abstract]   [Full Text] [Related]  

  • 75. Acquired von Willebrand syndrome with inhibitors both to factor VIII clotting activity and ristocetin-induced platelet aggregation.
    Stableforth P; Tamagnini GL; Dormandy KM
    Br J Haematol; 1976 Aug; 33(4):565-73. PubMed ID: 1087568
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Platelet-bound ristocetin aggregation factor in normal subjects and patients with von Willebrand's disease.
    Green D; Potter EV
    J Lab Clin Med; 1976 Jun; 87(6):976-86. PubMed ID: 778313
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A radial immunodiffusion method for the assay of factor VIII:C Antigen (VIII:C Ag) in plasma.
    McLellan DS; Devlin JD; Groom P; Aronstam A
    Br J Haematol; 1981 Feb; 47(2):295-305. PubMed ID: 6781528
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Hemophilia A and von Willebrand's disease: the relationship examined.
    Bennett B
    Ann N Y Acad Sci; 1975 Jan; 240():109-16. PubMed ID: 1089378
    [No Abstract]   [Full Text] [Related]  

  • 79. An immunoradiometric assay for procoagulant factor VIII antigen: results in haemophilia, von Willebrand's disease and fetal plasma and serum.
    Peake IR; Bloom AL; Giddings JC; Ludlam CA
    Br J Haematol; 1979 Jun; 42(2):269-81. PubMed ID: 313808
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Nature of haemophilia and von Willebrand's disease.
    Ekert H; Muntz RH
    Aust N Z J Med; 1974 Feb; 4(1):66-70. PubMed ID: 4602351
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.